Markus Flepp

8k citations
99 papers · 6.8k · 4 hit papers · h-index 39

Impact in

  • Virology top 0.5%
    • HIV Research and Treatment
    • HIV/AIDS Research and Interventions
    • HIV/AIDS drug development and treatment

Papers in

    • HIV/AIDS drug development and treatment 27
    • HIV/AIDS Research and Interventions 16
    • HIV Research and Treatment 18

Markus Flepp

97 papers receiving 6.4k citations

Markus Flepp's Hit Papers

Decreasing mortality and changing patterns of causes of death in the S wiss HIV C ohort S tudy 2012 · 314 citations
3140+9+19Years since publication250500750

Peers

Markus Flepp
Comparison fields: 5 of 118
  • Virology 1.3k
  • Infectious Diseases 3.4k
  • Emergency Medicine 806
  • Hepatology 797
  • Parasitology 165
Replace Esteban Ribera with:
Esteban Ribera Spain
Philippe Morlat France
Clifford L S Leen United Kingdom
Sven A. Danner Netherlands
Vincent Le Moing France
PHILIP E. TARR Switzerland
P. Yéni France
Federico Pulido Spain
Giuliano Rizzardini Italy
Josep Mallolas Spain
Markus Flepp relative to Esteban Ribera Spain Esteban Ribera's profile →
Citations per field
00.5×2×2.5×
Esteban Ribera · 1×
Citations per year

Countries citing papers authored by Markus Flepp

Since Specialization
Citations

This map shows the geographic impact of Markus Flepp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Flepp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Flepp more than expected).

Fields of papers citing papers by Markus Flepp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Flepp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Flepp. The network helps show where Markus Flepp may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Flepp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Flepp Line = papers co-authored together Markus Flepp links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study
Hit paper breakdown →
1999808
2
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
Hit paper breakdown →
2000757
3
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study
Hit paper breakdown →
1997531
4
Decreasing mortality and changing patterns of causes of death in the S wiss HIV C ohort S tudy
Hit paper breakdown →
2012314
5 2001281
6 2000232
7 2001203
8 1999198
9 2001174
10
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study.
1999147
11 1997141
12 2011128
13 2007119
14 2002114
15 2005110
16 1985109
17 1985107
18 1997105
19 2009104
20 2012104

About Markus Flepp

Markus Flepp is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Hepatology and Epidemiology, having authored 99 papers that have together received 6.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (27 papers), HIV Research and Treatment (18 papers), HIV/AIDS Research and Interventions (16 papers), HIV-related health complications and treatments (14 papers), Hepatitis C virus research (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Viral-associated cancers and disorders (5 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). The work is most often cited by research in Virology (1.3k citations), Infectious Diseases (3.4k citations), Emergency Medicine (806 citations), Hepatology (797 citations) and Parasitology (165 citations). Markus Flepp has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include Pietro Vernazza, Amalio Telenti, Bernard J. Hirschel, Hansjakob Furrer, Patrick B. Francioli, Bruno Ledergerber, Martin Rickenbach, Matthias Egger, Philippe Sudre and Rainer K. Weber. Their work appears in journals such as AIDS, Antiviral Therapy, Clinical Infectious Diseases, The Lancet and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact